Big biotech, Biotech, Financing

Isis Pharmaceuticals proposes $175 million in private financing

Posted on 07 August 2012

Tags: , ,

Isis Pharmaceuticals intends to offer, subject to market and other considerations, $175.0 million aggregate principal amount of Convertible Senior Notes due 2019 in a private placement financing.

Isis also intends to grant to the initial purchasers of the Convertible Notes a 30-day option to purchase up to an additional $26.25 million aggregate principal amount of the Convertible Notes solely to cover over-allotments.

Isis may use a portion of the net proceeds of this offering to repurchase a portion of its outstanding 2 5/8% Convertible Subordinated Notes due 2027 in individually negotiated transactions concurrently with the offering.

The Convertible Notes will be general unsecured senior obligations of Isis and will accrue interest payable semiannually in arrears.

The interest rate, conversion rate and other terms of the Convertible Notes will be determined at the time of pricing of the offering.

For further deal information visit Current Agreements (subscription required)

 

Related

Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary

Report: Royalty Financing Partnering Terms and Agreements

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard– latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Print Friendly, PDF & Email

Leave a Reply